학술논문
'학술논문'
에서 검색결과 543건 | 목록
1~20
Academic Journal
Juan Ramon, Albert; Parmar, Chaitanya; Carrasco-Zevallos, Oscar M.; Csiszer, Carlos; Yip, Stephen S. F.; Raciti, Patricia; Stone, Nicole L.; Triantos, Spyros; Quiroz, Michelle M.; Crowley, Patrick; Batavia, Ashita S.; Greshock, Joel; Mansi, Tommaso; Standish, Kristopher A.
Nature Communications. 15(1)
Academic Journal
Bastick, Patricia; Sewak, Sanjeev; Tran, Ben; Pichler, Martin; Shariat, Shahrokh; Rottey, Sylvie; Schatteman, Peter; Schrijvers, Dirk; Verschaeve, Vincent; Vulsteke, Christof; Barros Leite Ferreira, Luiza Aleixo; de Santana Gomes Andrea Juliana, Pereira; Junior, Joao Antonio; Azevedo, Sergio; Bastos, Diogo; Borges, Giuliano; Dettino, Aldo; Antonio, Pires Luis; Luz, Murilo; Martins, Suelen; Mota, Jose Mauricio; Toledo, Joseane; Eigl, Bernhard; Finch, Daygen; Gingerich, Joel; Dong, Haiying; Huang, Jian; Jin, Jie; Pan, Hongming; Sun, Zhongquan; Tian, Ye; Wan, Ben; Wu, Bin; Xu, Ting; Xue, Wei; Zhou, Fangjian; Barthelemy, Philippe; Borchiellini, Delphine; Calcagno, Fabien; Carnot, Aurelien; Cornillon, Pierre; Delva, Remy; Emambux, Sheik; Houede, Nadine; Laguerre, Brigitte; Lauridant, Géraldine; Loriot, Yohann; Mahammedi, Hakim; Maillet, Denis; Pouessel, Damien; Roubaud, Guilhem; Schlurmann-Constans, Friederike; Tosi, Diego; Zanetta, Sylvie; Banek, Severine; Feyerabend, Susan; Kramer, Mario; Niegisch, Guenther; Nuhn, Philipp; Schnabel, Marco; Wuelfing, Christian; Baka, Sofia; Bamias, Aristotelis; Fountzilas, George; Kalofonos, Harabolos; Karalis, Konstantinos; Kotsakis, Athanasios; Timotheadou, Eleni; Landherr, Laszlo; Mangel, Laszlo; Pe’er, Avivit; Levratovsky, Meital; Basso, Umberto; Battelli, Nicola; Cavo, Alessia; De Giorgi, Ugo; Doni, Laura; Galli, Luca; Gigante, Maria Olga; Guadalupi, Valentina; Maio, Michele; Milesi, Laura; Nolè, Franco; Scagliotti, Giorgio; Tortora, Giampaolo; Fukasawa, Satoshi; Harabayashi, Toru; Kamiya, Naoto; Kawahara, Takashi; Kawakita, Mutsushi; Matsubara, Nobunaki; Matsumoto, Kazumasa; Nishimura, Kazuo; Rikiya, Taoka; Shimizu, Nobuaki; Tagaki, Toshio; Kang, Taek Won; Kim, Jwa Hoon; Kim, SeHyun; Lee, Hyo Jin; Lee, Yun-Gyoo; Rha, Sun Young; Seo, Ho Kyung; Los, Maartje; Zurawski, Bogdan; Cortes, Paulo; Faustino, Catia; Vau, Nuno Sineiro; da Luz, Ricardo; Atduev, Vagif; Kirtbaya, Dmitry; Kopyltsov, Evgeny; Lykov, Aleksandr; Marat, Urmantsev; Orlov, Sergey; Penkov, Konstantin; Pirmagomedov, Albert; Semenov, Andrey; Varlamov, Sergey; Anguera, Georgia; Domenech, Montserrat; Girones, Regina; Gonzalez del Alba, Aranzazu; Milagro, Nuria Lainez; Luque, Raquel; Ortega, Esther Martínez; Mellado, Begoña; Méndez Vidal, María Jose; Fernandez, Esteban Nogales; Valderrama, Begoña Perez; Marín, Alvaro Pinto; Santander, Carmen; Huang, Yi-Hsiu; Su, Wen-Pin; Wu, Hung-Chan; Wu, WenJeng; Yu, Kai-Jie; Bilici, Ahmet; Goker, Erdem; Gumus, Mahmut; Karaoglu, Aziz; Kefeli, Umut; Köse, Fatih; Ozguroglu, Mustafa; Tural, Deniz; Turk, Haci; Yalcin, Suayib; Bondarenko, Igor; Khareba, Gennadii; Kidik, Yana; Lychkovskyy, Oleksandr; Sakalo, Valerii; Shevnia, Serghii; Stakhovskyy, Eduard; Bahl, Amit; Crabb, Simon; Powles, Thomas; Sankey, Peter; Sarwar, Mohammad; Benedetto, Pasquale; Burgess, Earle; Dawson, Nancy; Doshi, Gurjyot; Fleming, Mark; Maly, Joseph; Parikh, Mamta; Waterhouse, David; Siefker-Radtke, A.O.; Matsubara, N.; Park, S.H.; Huddart, R.A.; Burgess, E.F.; Özgüroğlu, M.; Valderrama, B.P.; Laguerre, B.; Basso, U.; Triantos, S.; Akapame, S.; Kean, Y.; Deprince, K.; Mukhopadhyay, S.; Loriot, Y.
In Annals of Oncology January 2024 35(1):107-117
Academic Journal
Bengio, Ruben; Cutuli, Hernan; Salinas, Jorge; Ameye, Filip; Joniau, Steven; Rodrigues da Rosa, Diogo; Martins da Trindade, Karine; Luz, Murilo Almeida; Bavaresco, Mario Henrique; de Paula, Adriano; Santiag, Jose; Wang, Shaogang; Ye, Dingwei; Boegemann, Martin; Roghmann, Florian; Heidrich, Albert; Hellmis, Eva; Faba, Óscar Rodriguez; Dominguez, Jose Luis; Mathieu, Romain; Colombel, Marc; Bladou, Franck; Artignan, Xavier; Vasdev, Nikhil; Shimpi, Rajendra; Guadalupi, Valentina; Tambaro, Rosa; Sirotova, Zuzana; Spada, Massimiliano; Necchi, Andrea; Nakatsu, Hiroomi; Kikuchi, Eiji; Shimizu, Nobuaki; Kanao, Kent; Sumitomo, Makoto; Naito, Yushi; Ham, Won Sik; Jung, Seung-Il; Ha, Hongkoo; Joo, Kwan Joong; Ku, Ja Hyeon; Seo, Ho Kyung; Yun, Seokjoong; Kolodziej, Anna; Lawinski, Janusz; Morris, David; Daneshmand, Siamak; Mian, Badar; Lee, Eugene; Catto, J.W.F.; Tran, B.; Rouprêt, M.; Gschwend, J.E.; Loriot, Y.; Nishiyama, H.; Redorta, J.P.; Daneshmand, S.; Hussain, S.A.; Cutuli, H.J.; Procopio, G.; Guadalupi, V.; Vasdev, N.; Naini, V.; Crow, L.; Triantos, S.; Baig, M.; Steinberg, G.
In Annals of Oncology January 2024 35(1):98-106
Academic Journal
Erik Meijaard; Douglas Sheil; Julie Sherman; Liana Chua; Safwanah Ni'matullah; Kerrie Wilson; Marc Ancrenaz; Darmawan Liswanto; Serge A. Wich; Benoit Goossens; Hjalmar S. Kühl; Maria Voigt; Yaya Rayadin; Yuyun Kurniawan; Agus Trianto; Dolly Priatna; Graham L. Banes; Emily Massingham; John Payne; Andrew J. Marshall
Oryx, Vol 57, Pp 566-577 (2023)
Academic Journal
Loriot Y; Department of Cancer Medicine, INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Triantos S; Janssen Research & Development, Spring House, PA, USA.; Deprince K; Janssen Research & Development, Beerse, Belgium.; Siefker-Radtke AO; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publisher: Taylor & Francis Country of Publication: England NLM ID: 101256629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1744-8301 (Electronic) Linking ISSN: 14796694 NLM ISO Abbreviation: Future Oncol Subsets: In Process; MEDLINE
Academic Journal
Demirdjian L; Janssen Research & Development, Spring House, Pennsylvania, USA.; Triantos S; Janssen Research & Development, Spring House, Pennsylvania, USA.; Standish K; Janssen Research & Development, Spring House, Pennsylvania, USA.; Thomas S; Janssen Research & Development, Spring House, Pennsylvania, USA.; Xia Q; Janssen Research & Development, Spring House, Pennsylvania, USA.; Zhang J; Janssen Research & Development, Spring House, Pennsylvania, USA.; Greshock J; Janssen Research & Development, Spring House, Pennsylvania, USA.; Paone J; Aetion, New York, New York, USA.; Sheridan P; Aetion, New York, New York, USA.; Pant S; The University of Texas, MD Anderson Cancer Center, Houston, Texas, USA.; Massard C; Gustave Roussy, Université Paris Saclay, Villejuif, France.; Reardon DA; Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA.; Loriot Y; Gustave Roussy, Université Paris Saclay, Villejuif, France.; Schuler M; West German Cancer Center, University Hospital Essen, Essen, Germany.; Sweiti H; Janssen Research & Development, Spring House, Pennsylvania, USA.
Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print Cited Medium: Internet ISSN: 2045-7634 (Electronic) Linking ISSN: 20457634 NLM ISO Abbreviation: Cancer Med Subsets: MEDLINE
Academic Journal
Sri Sedjati; Ambariyanto Ambariyanto; Agus Trianto; Endang Supriyantini; Ali Ridlo; Muhammad S. Bahry; Rizky Rifatma Jezzi; Mahadika Fanindhita Sany
Jurnal Kelautan Tropis, Vol 23, Iss 1, Pp 127-135 (2020)
Academic Journal
Matsubara N; Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan. Electronic address: nmatsuba@east.ncc.go.jp.; Loriot Y; Department of Cancer Medicine, INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France.; Burgess EF; Department of Medical Oncology, Levine Cancer Institute, North Carolina, USA.; Park SH; Division of Haematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.; Huddart RA; Department of Medical Oncology, Levine Cancer Institute, North Carolina, USA; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK; Royal Marsden NHS Foundation Trust, London, UK.; Ku JH; Department of Urology, Seoul National University Hospital, Seoul, South Korea.; Tran B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia.; Huang J; Department of Urology, Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, China.; Huang YH; Department of Urology, Taipei Veterans General Hospital and National Yang Ming Chiao Tung University, Taipei, Taiwan.; Nishimura K; Department of Urology, Osaka International Cancer Institute, Osaka, Japan.; Shimizu N; Department of Urology, Gunma Prefectural Cancer Center, Gunma, Japan.; Xing N; Department of Urology, National Cancer Center, Cancer Hospital of the Chinese Academy of Medical Sciences, Beijing, China.; Xue W; Department of Urology, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Hemaya R; Janssen Medical Affairs Asia Pacific, Victoria, Australia.; Zhuo J; Janssen Research & Development, Shanghai, China.; Deprince K; Janssen Research & Development, Beerse, Belgium.; Triantos S; Janssen Research & Development, Spring House, Pennsylvania, USA.; Siefker-Radtke AO; Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Texas, USA.
Publisher: Elsevier Country of Publication: United States NLM ID: 101260955 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1938-0682 (Electronic) Linking ISSN: 15587673 NLM ISO Abbreviation: Clin Genitourin Cancer Subsets: MEDLINE
Electronic Resource
Siefker-Radtke, A. O.; Matsubara, N.; Park, S. H.; Huddart, R. A.; Burgess, E. F.; Ozguroglu, M.; Valderrama, B. P.; Laguerre, B.; Basso, U.; Triantos, S.; Akapame, S.; Kean, Y.; Deprince, K.; Mukhopadhyay, S.; Loriot, Y.; Bastick, P.; Sewak, S.; Tran, B.; Pichler, M.; Shariat, S.; Rottey, S.; Schatteman, P.; Schrijvers, D.; Verschaeve, V.; Vulsteke, C.; Barros Leite Ferreira, L. A.; de Santana Gomes Andrea Juliana, P.; Junior, J. A.; Azevedo, S.; Bastos, D.; Borges, G.; Dettino, A.; Antonio, P. L.; Luz, M.; Martins, S.; Mota, J. M.; Toledo, J.; Eigl, B.; Finch, D.; Gingerich, J.; Dong, H.; Huang, J.; Jin, J.; Pan, H.; Sun, Z.; Tian, Y.; Wan, B.; Wu, B.; Xu, T.; Xue, W.; Zhou, F.; Barthelemy, P.; Borchiellini, D.; Calcagno, F.; Carnot, A.; Cornillon, P.; Delva, R.; Emambux, S.; Houede, N.; Lauridant, G.; Mahammedi, H.; Maillet, D.; Pouessel, D.; Roubaud, G.; Schlurmann-Constans, F.; Tosi, Domiziano Dario; Zanetta, S.; Banek, S.; Feyerabend, S.; Kramer, M.; Niegisch, G.; Nuhn, P.; Schnabel, M.; Wuelfing, C.; Baka, S.; Bamias, A.; Fountzilas, G.; Kalofonos, H.; Karalis, K.; Kotsakis, A.; Timotheadou, E.; Landherr, L.; Mangel, L.; Pe'Er, A.; Levratovsky, M.; Battelli, N.; Cavo, A.; De Giorgi, U.; Doni, L.; Galli, L.; Gigante, M. O.; Guadalupi, V.; Maio, M.; Milesi, L.; Nole, F.; Scagliotti, G.; Tortora, Giampaolo; Fukasawa, S.; Harabayashi, T.; Kamiya, N.; Kawahara, T.; Kawakita, M.; Matsumoto, K.; Nishimura, K.; Rikiya, T.; Shimizu, N.; Tagaki, T.; Kang, T. W.; Kim, J. H.; Kim, S.; Lee, H. J.; Lee, Y. -G.; Rha, S. Y.; Seo, H. K.; Los, M.; Zurawski, B.; Cortes, P.; Faustino, C.; Vau, N. S.; da Luz, R.; Atduev, V.; Kirtbaya, D.; Kopyltsov, E.; Lykov, A.; Marat, U.; Orlov, S.; Penkov, K.; Pirmagomedov, A.; Semenov, A.; Varlamov, S.; Anguera, G.; Domenech, M.; Girones, R.; Gonzalez del Alba, A.; Milagro, N. L.; Luque, R.; Ortega, E. M.; Mellado, B.; Mendez Vidal, M. J.; Fernandez, E. N.; Marin, A. P.; Santander, C.; Huang, Y. -H.; Su, W. -P.; Wu, H. -C.; Wu, W.; Yu, K. -J.; Bilici, A.; Goker, E.; Gumus, M.; Karaoglu, A.; Kefeli, U.; Kose, F.; Tural, D.; Turk, H.; Yalcin, S.; Bondarenko, I.; Khareba, G.; Kidik, Y.; Lychkovskyy, O.; Sakalo, V.; Shevnia, S.; Stakhovskyy, E.; Bahl, A.; Crabb, S.; Powles, T.; Sankey, P.; Sarwar, M.; Benedetto, P.; Burgess, E.; Dawson, N.; Doshi, G.; Fleming, M.; Maly, J.; Parikh, M.; Waterhouse, D.; Tosi D.; Tortora G. (ORCID:0000-0002-1378-4962)
Academic Journal
Eisner JR; GeneCentric Therapeutics, Inc., Durham, North Carolina.; de Jong FC; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Shibata Y; GeneCentric Therapeutics, Inc., Durham, North Carolina.; Mayhew GM; GeneCentric Therapeutics, Inc., Durham, North Carolina.; Davison JM; GeneCentric Therapeutics, Inc., Durham, North Carolina.; Carcione J; Janssen Research & Development, LLC, A Johnson & Johnson Company, New Brunswick, New Jersey.; Pappan KL; GeneCentric Therapeutics, Inc., Durham, North Carolina.; Thomas S; Janssen Research & Development, LLC, A Johnson & Johnson Company, New Brunswick, New Jersey.; Triantos S; Janssen Research & Development, LLC, A Johnson & Johnson Company, New Brunswick, New Jersey.; Santiago-Walker A; Janssen Research & Development, LLC, A Johnson & Johnson Company, New Brunswick, New Jersey.; Baig M; Janssen Research & Development, LLC, A Johnson & Johnson Company, New Brunswick, New Jersey.; Milburn MV; GeneCentric Therapeutics, Inc., Durham, North Carolina.; Beebe KD; GeneCentric Therapeutics, Inc., Durham, North Carolina.; Zuiverloon TCM; Department of Urology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Journal of Oral Pathology & Medicine. Jul 01, 2010 39(6):506-507
Electronic Resource
Pant, S; Schuler, M; Iyer, G; Witt, O; Doi, T; Qin, S; Tabernero, J; Reardon, D; Massard, C; Minchom, A; Lugowska, I; Carranza, O; Arnold, D; Gutierrez, M; Winter, H; Stuyckens, K; Crow, L; Najmi, S; Hammond, C; Thomas, S; Santiago-Walker, A; Triantos, S; Sweiti, H; Loriot, Y; Greco, M; Coward, J; Joshua, A; Karapetis, C; Hart, C; Zhang, A; Prenen, H; Goeminne, J; Machiels, J; Rottey, S; Corassa, M; Molin, G; Tiscoski, K; Jardim, D; Mak, M; Fu, W; Yao, H; Huang, J; Jiang, H; Chen, B; Yan, D; Yang, Y; Le Tourneau, C; Penel, N; Salas, S; Blay, J; Brachet, P; Durando, X; Emambux, S; Ravaud, A; Folprecht, G; Ahrens, M; Golf, A; Haag, G; Lordick, F; Desuki, A; Cazzaniga, M; Ciardiello, F; Milella, M; Koyama, T; Hirooka, Y; Okamoto, W; Aogi, K; Kuboki, Y; Lee, J; Kim, S; Ahn, M; Chang, J; Kim, Y; Nam, D; Park, J; Paz-Ares, L; Moreno, V; Cervantes, A; Calvo, M; Falcon, A; Gonzalez, A; Martinez Bueno, A; Garcia-Corbacho, J; Longo, F; Yen, C; Chen, J; Hou, M; Chao, Y; Rau, K; Chiu, T; Feng, Y; Hsu, C; Huang, W; Lai, K; Yeh, S; Palmer, D; Welsh, L; Plummer, R; Bilen, M; Arrowsmith, E; Spigel, D; Zandberg, D; Doroshow, D; Lu-Emerson, C; Moezi, M; Paulson, S; Ward, P; Chaves, J; Grigg, C; Hussein, A; Manda, S; Monticelli, M; Qamar, R; Richey, S; Tamura, D; Wilks, S; Pant S.; Schuler M.; Iyer G.; Witt O.; Doi T.; Qin S.; Tabernero J.; Reardon D. A.; Massard C.; Minchom A.; Lugowska I.; Carranza O.; Arnold D.; Gutierrez M.; Winter H.; Stuyckens K.; Crow L.; Najmi S.; Hammond C.; Thomas S.; Santiago-Walker A.; Triantos S.; Sweiti H.; Loriot Y.; Greco M. A.; Coward J.; Joshua A.; Karapetis C.; Hart C.; Zhang A.; Prenen H.; Goeminne J. -C.; Machiels J. -P.; Rottey S.; Corassa M.; Molin G. Z. D.; Tiscoski K.; Jardim D. L. F.; Mak M.; Fu W.; Yao H.; Huang J.; Jiang H.; Chen B.; Yan D.; Yang Y.; Le Tourneau C.; Penel N.; Salas S.; Blay J. -Y.; Brachet P. -E.; Durando X.; Emambux S.; Ravaud A.; Folprecht G.; Ahrens M.; Golf A.; Haag G. M.; Lordick F.; Desuki A.; Cazzaniga M.; Ciardiello F.; Milella M.; Koyama T.; Hirooka Y.; Okamoto W.; Aogi K.; Kuboki Y.; Lee J.; Kim S. -B.; Ahn M. -J.; Chang J. H.; Kim Y. -M.; Nam D. -H.; Park J. -S.; Paz-Ares L.; Moreno V.; Cervantes A.; Calvo M.; Falcon A.; Gonzalez A.; Martinez Bueno A.; Garcia-Corbacho J.; Longo F.; Yen C. -J.; Chen J. -S.; Hou M. -F.; Chao Y.; Rau K. -M.; Chiu T. -J.; Feng Y. -H.; Hsu C. -H.; Huang W. -T.; Lai K. -M.; Yeh S. -P.; Palmer D.; Welsh L.; Plummer R.; Bilen M.; Arrowsmith E.; Spigel D. R.; Zandberg D. P.; Doroshow D.; Lu-Emerson C.; Moezi M.; Paulson S.; Reardon D.; Ward P.; Chaves J.; Grigg C.; Hussein A.; Manda S.; Monticelli M.; Qamar R.; Richey S. L.; Tamura D.; Wilks S.
Academic Journal
Matsubara N; Department of Medical Oncology, National Cancer Center Hospital East, 6-5-1 Kashiwanoha, Kashiwa, Chiba, 277-8577, Japan. nmatsuba@east.ncc.go.jp.; Miura Y; Department of Medical Oncology, Toranomon Hospital, 2-2-2 Toranomon, Minato-ku, Tokyo, 105-8470, Japan.; Nishiyama H; Department of Urology, Institute of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.; Taoka R; Department of Urology, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho, Kita-gun, Kagawa, 761-0793, Japan.; Kojima T; Department of Urology, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya, Aichi, 464-8681, Japan.; Shimizu N; Department of Urology, Gunma Prefectural Cancer Center, 3-39-22 Showa-machi, Maebashi, Gunma, 371-8511, Japan.; Hwang J; Department of Medical Affairs, Janssen Pharmaceutical K.K, 5-2-3 Nishikanda, Chiyoda-ku, Tokyo, 101-0065, Japan.; Ote T; Oncology Clinical Development Department, Clinical Science Division, Research and Development, Janssen Pharmaceutical K.K, 5-2-3 Nishikanda, Chiyoda-ku, Tokyo, 101-0065, Japan.; Oyama R; Research and Development, Janssen Pharmaceutical K.K, 5-2-3 Nishikanda, Chiyoda-ku, Tokyo, 101-0065, Japan.; Toyoizumi K; Statistics and Decision Sciences, Research and Development, Janssen Pharmaceutical K. K, 5-2-3 Nishikanda, Chiyoda-ku, Tokyo, 101-0065, Japan.; Mukhopadhyay S; Janssen Research and Development, 920 US Highway 202 S, Raritan, NJ, 08807, USA.; Triantos S; Janssen Research and Development, 1400 McKean Road, Spring House, PA, 19477, USA.; Deprince K; Janssen Research and Development, Turnhoutseweg 30, 2340, Beerse Anterwerpen, Belgium.; Loriot Y; Department of Cancer Medicine, INSERM U981, Gustave Roussy, Universite Paris-Saclay, 94800, Villejuif, France.
Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE
Academic Journal
Zhu W; Janssen Research & Development, Raritan, NJ, USA.; Baig M; Janssen Research & Development, Bridgewater, NJ, USA.; Naini V; Janssen Research & Development, San Diego, CA, USA.; De Meulder M; Janssen Research & Development, Beerse, Belgium.; Akapame S; Janssen Research & Development, Raritan, NJ, USA.; De Zwart L; Janssen Research & Development, Beerse, Belgium.; Haddish-Berhane N; Janssen Research & Development, Spring House, PA, USA.; Triantos S; Janssen Research & Development, Spring House, PA, USA.
Publisher: Wiley Country of Publication: United States NLM ID: 101572899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2160-7648 (Electronic) Linking ISSN: 2160763X NLM ISO Abbreviation: Clin Pharmacol Drug Dev Subsets: MEDLINE
Academic Journal
Van Sanden S; Janssen Pharmaceutica NV, Beerse, Belgium.; Youssef A; Janssen Cilag, Issy-les-Moulineaux, France.; Baculea S; Janssen Cilag Ltd, High Wycombe, United Kingdom.; Stubbs K; Janssen Cilag Ltd, High Wycombe, United Kingdom.; Triantos S; Johnson & Johnson, Spring House, Pennsylvania, United States.; Yuan Z; Cytel Inc., Rotterdam, Netherlands.; Daly C; Cytel Inc., Toronto, Ontario, Canada.
Publisher: Columbia Data Analytics, LLC Country of Publication: United States NLM ID: 101648581 Publication Model: eCollection Cited Medium: Internet ISSN: 2327-2236 (Electronic) Linking ISSN: 2326697X NLM ISO Abbreviation: J Health Econ Outcomes Res Subsets: PubMed not MEDLINE
Academic Journal
Erin McCauley; Ocky Karna Radjasa; Agus Trianto; Mitchell S. Crews; Alexander Smith; Gavin C. Smith; Paul Zerebinski; Agus Sabdono; Phillip Crews
ARKIVOC, Vol 2018, Iss 4, Pp 123-131 (2018)
Erdafitinib in Asian patients with advanced solid tumors: an open-label, single-arm, phase IIa trial
Academic Journal
Park, J.O.; Feng, Y.-H.; Su, W.-C.; Oh, D.-Y.; Keam, B.; Shen, L.; Kim, S.-W.; Liu, X.; Liao, H.; Qing, M.; Zhang, C.; Qian, J.; Tang, X.; Li, P.; Triantos, S.; Sweiti, H.
In: BMC Cancer . (BMC Cancer, December 2024, 24(1))
Academic Journal
Loriot Y; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Matsubara N; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Park SH; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Huddart RA; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Burgess EF; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Houede N; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Banek S; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Guadalupi V; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Ku JH; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Valderrama BP; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Tran B; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Triantos S; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Kean Y; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Akapame S; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Deprince K; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Mukhopadhyay S; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Stone NL; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).; Siefker-Radtke AO; From the Department of Cancer Medicine, INSERM Unité 981, Gustave Roussy, Université Paris-Saclay, Villejuif (Y.L.), the Department of Medical Oncology, Institut de Cancérologie du Gard, Centre Hospitalier Universitaire Caremeau, Nîmes (N.H.), and Montpellier University, Montpellier (N.H.) - all in France; the Department of Medical Oncology, National Cancer Center Hospital East, Chiba, Japan (N.M.); the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine (S.H.P.), and Seoul National University Hospital (J.H.K.) - both in Seoul, South Korea; the Section of Radiotherapy and Imaging, Institute of Cancer Research and Royal Marsden NHS Foundation Trust, Sutton, United Kingdom (R.A.H.); Medical Oncology, Levine Cancer Institute, Atrium Health, Charlotte, NC (E.F.B.); the Department of Urology, University Hospital Frankfurt, Goethe University Frankfurt, Frankfurt am Main, Germany (S.B.); the Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan (V.G.); the Department of Medical Oncology, Hospital Universitario Virgen del Rocío, Seville, Spain (B.P.V.); the Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia (B.T.); Janssen Research and Development, Spring House, PA (S.T., Y.K., S.A., N.L.S.); Janssen Research and Development, Beerse, Belgium (K.D.); Janssen Research and Development, Raritan, NJ (S.M.); and the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston (A.O.S.-R.).
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Academic Journal
Pant S; Department of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: spant@mdanderson.org.; Schuler M; Department of Medical Oncology, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany.; Iyer G; Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA.; Witt O; Hopp Children's Cancer Center (KiTZ), Heidelberg University Hospital, German Cancer Research Center and National Center for Tumor Diseases (NCT), Heidelberg, Germany.; Doi T; National Cancer Center Hospital East, Kashiwa, Japan.; Qin S; Jinling Hospital, Nanjing University of Chinese Medicine, Nanjing, China.; Tabernero J; Vall d'Hebron Hospital Campus and Institute of Oncology (VHIO), IOB-Quiron, Barcelona, Spain.; Reardon DA; Center for Neuro-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA.; Massard C; Le Kremlin Bicêtre-France INSERM U1030, Molecular Radiotherapy, Gustave Roussy, Université Paris-Saclay, Paris, France.; Minchom A; The Royal Marsden NHS Foundation Trust, Sutton, UK.; Lugowska I; Department of Soft Tissue/Bone Sarcoma and Melanoma, Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie-Panstwowy Instytut Badawczy, Warsaw, Poland.; Carranza O; Hospital Privado de Comunidad de Mar del Plata, Mar del Plata, Argentina.; Arnold D; Department of Oncology, AK Altona, Asklepios Tumourzentrum Hamburg, Hamburg, Germany.; Gutierrez M; John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.; Winter H; Bristol Haematology and Oncology Centre, Bristol, UK.; Stuyckens K; Janssen Research & Development, Beerse, Belgium.; Crow L; Janssen Research & Development, Spring House, PA, USA.; Najmi S; Janssen Research & Development, Spring House, PA, USA.; Hammond C; Janssen Research & Development, Spring House, PA, USA.; Thomas S; Janssen Research & Development, Spring House, PA, USA.; Santiago-Walker A; Janssen Research & Development, Spring House, PA, USA.; Triantos S; Janssen Research & Development, Spring House, PA, USA.; Sweiti H; Janssen Research & Development, Spring House, PA, USA.; Loriot Y; Department of Cancer Medicine, INSERM U981, Gustave Roussy, Université Paris-Saclay, Villejuif, France. Electronic address: Yohann.LORIOT@gustaveroussy.fr.
Publisher: Lancet Pub. Group Country of Publication: England NLM ID: 100957246 Publication Model: Print Cited Medium: Internet ISSN: 1474-5488 (Electronic) Linking ISSN: 14702045 NLM ISO Abbreviation: Lancet Oncol Subsets: MEDLINE
Academic Journal
Gynecologic Oncology. 154:12-13
검색 결과 제한하기
제한된 항목
[검색어] Triantos, S.
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어